• Splicing and Stability Time TRIM46 During Axon Formation

  2026-09-24

  The study shows that TRIM46 protein appears during axon formation through coordinated changes in transcription, alternative splicing, mRNA decay, and protein stability. Its results position two independently regulated exons as a temporal and neural-specific control system, while indicating that TRIM46 is instructive for AnkG localization but not invariably required for it.

• H 89 2HCl for PKA Signaling Workflows

  2026-09-23

  H 89 2HCl enables controlled interrogation of cAMP/PKA signaling, from phosphorylation assays to neurite-growth and neuroinflammation models. This guide translates its biochemical selectivity into practical workflows while showing how to separate PKA-dependent effects from concentration-dependent off-target activity.

• Catalpol in Diabetes: Pharmacology, PK, and Safety

  2026-09-22

  The reference review integrates preclinical evidence that Catalpol, also known as Catalpinoside, may improve glucose regulation and protect against diabetic kidney, cardiovascular, nervous-system, and bone complications through multi-pathway control of inflammation, oxidative stress, apoptosis, and metabolism. Its discussion of pharmacokinetics and safety is particularly useful for interpreting animal dosing, blood–brain barrier penetration, oral administration potential, and the limitations that remain before clinical translation.

• D-Lin-MC3-DMA: From Mechanism to Translation

  2026-09-22

  D-Lin-MC3-DMA is more than a familiar ionizable lipid: it is a framework for connecting pH-responsive chemistry, RNA payload biology, machine-learning-guided formulation, and translational decision-making. This article examines how to use MC3 rationally across hepatic gene silencing and mRNA delivery while respecting the limits of preclinical evidence.

• PR-619: A Mechanistic Probe for DUB Biology

  2026-09-21

  PR-619 is a reversible deubiquitylating enzymes inhibitor for resolving how ubiquitin signaling, proteostasis, autophagy, and cell-state phenotypes interact. This article connects assay design for PR-619 with the progenitor T-cell analysis framework used in a landmark tumor-immunology study.

• Chaperone-Mediated Autophagy in Muscle Aging

  2026-09-21

  The reference study identifies chaperone-mediated autophagy (CMA) as an active regulator of skeletal-muscle maintenance rather than a passive response to ageing. Using muscle-specific Lamp2a deficiency, proteomics, calcium assays and aged-mouse rescue experiments, the authors connect declining CMA to SERCA dysfunction, abnormal calcium handling and progressive myopathy.

• 2X Taq PCR Master Mix for C. elegans Studies

  2026-09-20

  Build faster C. elegans genotyping, cloning, and sequence-verification workflows with a ready-to-use Taq formulation and integrated gel-loading dye. The mix is especially useful for testing pheromone-signaling models because it supports endpoint PCR, direct gel loading, and TA cloning without adding a separate loading-buffer step.

• Bifidobacterium, FMT, and PET in Chronic HE

  2026-09-19

  This 2025 European Journal of Neuroscience study compares Bifidobacterium and fecal microbiota transplantation in bile duct ligation rats with chronic hepatic encephalopathy. Its main innovation is the use of regional [18F]PBR146 micro-PET/CT imaging to detect treatment-associated neuroinflammatory differences that were not evident in global brain uptake, behavioral testing, or circulating cytokines.

• MG-262: Reversible Proteasome Inhibition

  2026-09-19

  MG-262, also called Z-Leu-Leu-Leu-B(OH)2, is a cell-permeable, reversible inhibitor of proteasome chymotryptic activity. Its controlled use can support proteasome inhibition assay design, apoptosis research, cell cycle arrest studies, and mechanistic analysis of muscle proteostasis.

• Grazoprevir Hydrate: From Protease Biology to Translation

  2026-09-18

  A translational framework for using Grazoprevir hydrate and MK-5172 hydrate to connect NS3/4A protease biology, genotype-aware assay design, resistance strategy, pharmacokinetics, and clinically relevant HCV research populations.

• Bortezomib (PS-341): Proteasome Research Guide

  2026-09-17

  Bortezomib, also called PS-341, is a reversible 20S proteasome inhibitor used in apoptosis assays, proteostasis studies, and approved cancer treatment. Product-reported benchmarks include 0.1 µM activity in H460 cells and 3.5–5.6 nM activity in canine melanoma cell lines.

• FGF19–TRIM21–ANXA2 Axis in NPC Angiogenesis

  2026-09-17

  The reference study identifies an FGF19–TRIM21–ANXA2 regulatory axis that links nasopharyngeal carcinoma progression to tumor angiogenesis. Its combination of clinical profiling, cellular assays, animal models, and ubiquitination analysis supports FGF19 as a candidate biomarker and clarifies how altered protein turnover may enhance the vascular tumor microenvironment.

• Curcumol, Methionine Metabolism, and HSC Death

  2026-09-16

  A 2026 study identifies disruption of methionine metabolism as a mechanistic component of curcumol-induced, autophagy-dependent death in hepatic stellate cells. Its partial rescue by S-adenosylmethionine links methyl-donor metabolism to antifibrotic cell-state control while highlighting important limits for translation beyond the LX-2 model.

• Staurosporine: Kinase Inhibitor Research Guide

  2026-09-16

  Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor used to interrogate kinase signaling and induce apoptosis in cancer cell lines. Its activity against PKC isoforms, receptor tyrosine kinase autophosphorylation, and VEGF-driven angiogenesis is useful for cancer research, but its breadth limits pathway-specific interpretation.

• Berberine, Tuft Cells, and Bone Loss

  2026-09-15

  A 2026 Phytomedicine study identifies a gut–bone mechanism in which berberine increases microbiota-derived butyrate, activates GPR41, and expands intestinal tuft cells during estrogen deficiency. Using ovariectomized rodents, Trpm5-deficient models, organoids, microbiome profiling, and osteoimmune analyses, the work connects barrier repair with restoration of the Th17/Treg balance and reduced bone resorption.

8451 records 1/564 page Next 12345 下5页 Last page